Thrombophilia testing in patients with portal vein thrombosis.
Adult
Anticoagulants
/ therapeutic use
Antiphospholipid Syndrome
/ blood
Antithrombins
/ blood
Case-Control Studies
Denmark
/ epidemiology
Factor V
/ genetics
Factor VIII
/ metabolism
Female
Humans
Lupus Coagulation Inhibitor
/ blood
Male
Middle Aged
Mutation
Portal Vein
/ metabolism
Prevalence
Protein C
/ metabolism
Protein C Deficiency
/ blood
Protein S
/ metabolism
Prothrombin
/ genetics
Thrombophilia
/ blood
Venous Thrombosis
/ blood
Portal vein
anticoagulants
cirrhosis
thrombophilia
venous thrombosis
Journal
Scandinavian journal of clinical and laboratory investigation
ISSN: 1502-7686
Titre abrégé: Scand J Clin Lab Invest
Pays: England
ID NLM: 0404375
Informations de publication
Date de publication:
Dec 2020
Dec 2020
Historique:
pubmed:
8
10
2020
medline:
12
10
2021
entrez:
7
10
2020
Statut:
ppublish
Résumé
Portal vein thrombosis (PVT) is a rare but severe condition. Several risk factors predispose to PVT. However, it remains unclear to which degree thrombophilia contributes to the risk of PVT and whether PVT patients should be routinely referred for thrombophilia testing. The aim of the present study was to investigate the prevalence of thrombophilia in PVT patients to clarify the relevance of thrombophilia testing in PVT patients. Clinical data and results from thrombophilia investigations were systematically obtained from all PVT patients referred to Centre for Hemophilia and Thrombosis, Aarhus University Hospital, Denmark for thrombophilia testing between 1
Identifiants
pubmed: 33026843
doi: 10.1080/00365513.2020.1827289
doi:
Substances chimiques
Anticoagulants
0
Antithrombins
0
Lupus Coagulation Inhibitor
0
Protein C
0
Protein S
0
factor V Leiden
0
Factor V
9001-24-5
Prothrombin
9001-26-7
Factor VIII
9001-27-8
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM